5th Annual CBOutlook Denver once again grabs the issues and brings together leading experts in science, law, synthesize trends, 2018 Farm Bill, GW Pharma’s entry inpact on CBD and the Race for Market Share. 5thCBOutlook focuses on the answers, relevant research on complex CBD issues, and best practices.
Business is good for hemp-based CBD with 2018 expected to surpass $460Mil in North American sales. However, planning for the next major push into consumer and patient growth for CBD-- in its' many delivery forms -- will prove the next two years is critical for current and expanding hemp and cannabis platforms. Will you be ready? How will the 2018 US Farm Bill interact with the ability for domestic farmers to fully enter the market? How will GW Pharma's entry with their FDA-approved Epidiolex scramble consumer choices? Is clinical research and product innovation able to expand the consumer demand curve? Hear from 22 global experts on 9 panels and solo presentations. And as always, you take home the 4th edition of CBOutlook CDB DataDisk.